Evidence map›Paper›PMID 36974086›Full record

ArticleAdvances in radiation oncology

Effect of COVID-19 on Gynecologic Oncology Care: A Survey of Practicing Gynecologic Radiation Oncologists in the United States.

Jeffrey V Brower, Sylvia S Rhodes, Jill S Remick, Andrea L Russo, Emily F Dunn, Diandra N Ayala-Peacock, Daniel G Petereit, Kristin A Bradley, Neil K Taunk

Open access · goldAbstract read
In one paragraph

Article in Advances in radiation oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Jeffrey V BrowerDepartment of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Sylvia S RhodesRadiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Jill S RemickDepartment of Radiation Oncology, Winship Cancer Institute, Emory School of Medicine, Atlanta, Georgia.
Andrea L RussoDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts.
Emily F DunnDepartment of Radiation Oncology, Willamette Valley Cancer Institute and Research Center, Eugene, Oregon.
Diandra N Ayala-PeacockDepartment of Radiation Oncology, Duke Women's Health, Raleigh, North Carolina.
Daniel G PetereitDepartment of Radiation Oncology, Monument Health Cancer Care Institute, Rapid City, South Dakota.
Kristin A BradleyDepartment of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Neil K TaunkRadiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
University of Pennsylvania · USUniversity of Wisconsin–Madison · USDuke Raleigh Hospital · USEmory University · USMassachusetts General Hospital · USRapid City Regional Hospital · USWillamette Valley Cancer Institute and Research Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The COVID-19 pandemic has placed demands and limitations on the delivery of health care. We sought to assess the effect of COVID-19 on the delivery of gynecologic oncologic care from the perspective of practicing radiation oncologists in the United States. Methods and Materials: An anonymous online survey was created and distributed to preidentified radiation oncologists in the United States with clinical expertise in the management of gynecologic patients. The survey consisted of demographic questions followed by directed questions to assess specific patterns of care related to the COVID-19 pandemic. Results: A total of 47 of 96 invited radiation oncologists responded to the survey for a response rate of 49%. Fifty-six percent of respondents reported an increase in locally advanced cervical cancer with no similar increase for endometrial, vulvar, or vaginal patients. Most respondents (66%) reported a pause in surgical management, with a duration of 1 to 3 months being most common (61%). There was a reported increased use of shorter brachytherapy regimens during the pandemic. Most providers (61%) reported caring for at least 1 patient with a positive COVID-19 test. A pause or delay in treatment due to COVID-19 positivity was reported by 45% of respondents, with 55% reporting that patients chose to delay their own care because of COVID-19-related concerns. Total treatment times >8 weeks for patients with cervical cancer were observed by 33% of respondents, but occurred in >25% of patients. Conclusions: Data from this prospectively collected anonymous survey of practice patterns among radiation oncologists reveal that the COVID-19 pandemic resulted in delays initiating care, truncated brachytherapy treatment courses, and a reported increase in locally advanced cervical cancer cases at presentation. These data can be used as a means of self-assessment to ensure appropriate decision making for gynecologic patients during the endemic phase of COVID-19.

Identifiers

PMID36974086
PMCPMC9968481
OpenAlexW4322154940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.